“We revised the outlook to negative due to a deterioration in financial performance in fiscal 2015 — based on unaudited numbers — and uncertainty about recovery in fiscal 2016,” said S&P analyst Jennifer Soule.
If Clarendon achieves its financial performance target for fiscal 2016, S&P would consider returning its outlook to stable.
More articles on healthcare finance:
Healthcare spending hits $3 trillion under ACA: 10 things to know
Cleveland Clinic sees operating margin slip to 7.2% as investments drag down bottom line
Hospitals in Dallas and Forth Worth file for bankruptcy: 6 things to know
